Does Subacromial Injection With Glutamate Receptor Antagonist, Ketamine, Attenuate Pain in Rotator Cuff Tendinopathy?
Does Subacromial Injection With Glutamate Receptor (NMDAR) Antagonist, Ketamine, Attenuate Pain in Rotator Cuff Tendinopathy?
Sponsor: Helse Møre og Romsdal HF
A PHASE2/PHASE3 clinical study on Chronic Pain and Rotator Cuff Tendinitis, this trial is completed. The trial is conducted by Helse Møre og Romsdal HF and has accumulated 14 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2/PHASE3
Status: Unknown → Completed
-
Mar 2025 — Sep 2025 [monthly]
Unknown PHASE2/PHASE3
Status: Recruiting → Unknown
-
Sep 2024 — Mar 2025 [monthly]
Recruiting PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Mar 2023 — Jul 2024 [monthly]
Recruiting PHASE2_PHASE3
▶ Show 9 earlier versions
-
Apr 2022 — Mar 2023 [monthly]
Recruiting PHASE2_PHASE3
-
Mar 2021 — Apr 2022 [monthly]
Recruiting PHASE2_PHASE3
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE2_PHASE3
-
Feb 2020 — Jan 2021 [monthly]
Recruiting PHASE2_PHASE3
-
Sep 2019 — Feb 2020 [monthly]
Recruiting PHASE2_PHASE3
-
Jun 2018 — Sep 2019 [monthly]
Recruiting PHASE2_PHASE3
-
Mar 2018 — Jun 2018 [monthly]
Recruiting PHASE2_PHASE3
-
Jan 2018 — Mar 2018 [monthly]
Recruiting PHASE2_PHASE3
Status: Not Yet Recruiting → Recruiting
-
Jan 2017 — Jan 2018 [monthly]
Not Yet Recruiting PHASE2_PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Helse Møre og Romsdal HF
For direct contact, visit the study record on ClinicalTrials.gov .